BOLERO 3

This trial is looking at having EVEROLIMUS (also known as RAD001 and Afinitor) with Herceptin and chemotherapy for advanced breast cancer that is HER 2 Positive. It is for women whose breast cancer has come back in or near the breast (local recurrence), or has spread to another part of the body (metastatic or secondary breast cancer) after having other types of treatment. The Breast Cancer Clinical Trials Team  at St. Margaret's Hospital, Epping  and PAH, Harlow are recruiting patients into this trial  Details about this trial  are at  CancerHelp UK or by telephone 01279 827396.